Net Income Summary of Fujian Cosunter Pharmaceutical Co., Ltd.

Fujian Cosunter Pharmaceutical Co., Ltd.'s latest annual net income in 2023 was -348.58 Million CNY , down -173.61% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd.'s latest quarterly net income in 2024 Q3 was -34.6 Million CNY , down -61.73% from previous quarter.
Fujian Cosunter Pharmaceutical Co., Ltd. reported an annual net income of -127.4 Million CNY in 2022, down -265.19% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd. reported an annual net income of -34.88 Million CNY in 2021, down -335.33% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a quarterly net income of -34.6 Million CNY for 2024 Q3, down -61.73% from previous quarter.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a quarterly net income of -14.64 Million CNY for 2024 Q1, up 90.41% from previous quarter.

Annual Net Income Chart of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Net Income	Net Income Growth
2023	-348.58 Million CNY	-173.61%
2022	-127.4 Million CNY	-265.19%
2021	-34.88 Million CNY	-335.33%
2020	14.82 Million CNY	38.01%
2019	10.74 Million CNY	-34.84%
2018	16.48 Million CNY	-50.89%
2017	33.56 Million CNY	-49.46%
2016	66.41 Million CNY	-35.83%
2015	103.49 Million CNY	23.55%
2014	83.76 Million CNY	46.29%
2013	57.26 Million CNY	32.68%
2012	43.15 Million CNY	27.59%
2011	33.82 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-21.39 Million CNY	-46.11%
2024 Q3	-34.6 Million CNY	-61.73%
2024 Q1	-14.64 Million CNY	90.41%
2023 Q4	-152.76 Million CNY	-295.66%
2023 Q1	-63.3 Million CNY	-13.23%
2023 Q2	-93.9 Million CNY	-48.33%
2023 Q3	-38.61 Million CNY	58.88%
2023 FY	-348.58 Million CNY	-173.61%
2022 Q3	-45.27 Million CNY	-164.88%
2022 Q2	-17.09 Million CNY	-87.16%
2022 Q1	-9.13 Million CNY	36.39%
2022 Q4	-55.91 Million CNY	-23.5%
2022 FY	-127.4 Million CNY	-265.19%
2021 Q2	-18.86 Million CNY	-1165.93%
2021 Q4	-14.35 Million CNY	-317.96%
2021 Q3	-3.43 Million CNY	81.8%
2021 FY	-34.88 Million CNY	-335.33%
2021 Q1	1.77 Million CNY	1039.21%
2020 Q4	-188.46 Thousand CNY	-105.18%
2020 FY	14.82 Million CNY	38.01%
2020 Q1	1.83 Million CNY	155.9%
2020 Q3	3.64 Million CNY	-61.82%
2020 Q2	9.53 Million CNY	419.91%
2019 Q1	7.56 Million CNY	-27.66%
2019 Q4	-3.28 Million CNY	-222.08%
2019 FY	10.74 Million CNY	-34.84%
2019 Q3	2.68 Million CNY	-28.8%
2019 Q2	3.77 Million CNY	-50.06%
2018 Q2	-7.76 Million CNY	-164.2%
2018 Q1	12.08 Million CNY	192.18%
2018 Q4	10.45 Million CNY	512.6%
2018 FY	16.48 Million CNY	-50.89%
2018 Q3	1.7 Million CNY	121.98%
2017 Q4	4.13 Million CNY	90.85%
2017 Q1	20.39 Million CNY	185.19%
2017 FY	33.56 Million CNY	-49.46%
2017 Q2	6.86 Million CNY	-66.37%
2017 Q3	2.16 Million CNY	-68.4%
2016 Q4	7.15 Million CNY	-61.35%
2016 FY	66.41 Million CNY	-35.83%
2016 Q3	18.5 Million CNY	47.45%
2016 Q2	12.55 Million CNY	-55.49%
2016 Q1	28.19 Million CNY	35.08%
2015 Q4	20.87 Million CNY	-30.34%
2015 FY	103.49 Million CNY	23.55%
2015 Q3	29.96 Million CNY	19.39%
2015 Q2	25.1 Million CNY	-8.89%
2015 Q1	27.55 Million CNY	49.82%
2014 Q2	21.1 Million CNY	4.2%
2014 Q1	20.25 Million CNY	0.0%
2014 FY	83.76 Million CNY	46.29%
2014 Q4	18.38 Million CNY	-23.45%
2014 Q3	24.02 Million CNY	13.82%
2013 FY	57.26 Million CNY	32.68%
2012 FY	43.15 Million CNY	27.59%
2011 FY	33.82 Million CNY	0.0%

Peer Net Income Comparison of Fujian Cosunter Pharmaceutical Co., Ltd.

Name	Net Income	Net Income Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-1.68 Billion CNY	79.373%
Anhui Fengyuan Pharmaceutical Co., Ltd.	159.28 Million CNY	318.846%
Dong-E-E-Jiao Co.,Ltd.	1.15 Billion CNY	130.289%
Livzon Pharmaceutical Group Inc.	1.95 Billion CNY	117.843%
Hainan Haiyao Co., Ltd.	-106.48 Million CNY	-227.349%
Tus-Pharmaceutical Group Co., Ltd.	25.24 Million CNY	1480.73%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.45 Billion CNY	123.878%
Changchun High-Tech Industries (Group) Inc.	4.53 Billion CNY	107.691%
Apeloa Pharmaceutical Co.,Ltd	1.05 Billion CNY	133.031%
PKU HealthCare Corp.,Ltd.	44.35 Million CNY	885.881%
Chengdu Huasun Technology Group Inc., Ltd.	27.65 Million CNY	1360.291%
Dezhan Healthcare Company Limited	83.31 Million CNY	518.404%
Jinling Pharmaceutical Company Limited	99.65 Million CNY	449.805%
Jiuzhitang Co., Ltd.	297.41 Million CNY	217.208%
Huapont Life Sciences Co., Ltd.	302.12 Million CNY	215.38%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	618.89 Million CNY	156.324%
Shandong Wohua Pharmaceutical Co., Ltd.	58.76 Million CNY	693.172%
Hengkang Medical Group Co., Ltd.	30.77 Million CNY	1232.648%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	263.27 Million CNY	232.406%
Qianjiang Yongan Pharmaceutical Co., Ltd.	-12.31 Million CNY	-2731.172%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	-783.25 Million CNY	55.495%
Jinhe Biotechnology CO., LTD.	86.45 Million CNY	503.194%
Teyi Pharmaceutical Group Co.,Ltd	253.17 Million CNY	237.687%
Kunming Longjin Pharmaceutical Co., Ltd.	-70.94 Million CNY	-391.377%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-148.52 Million CNY	-134.694%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.04 Billion CNY	133.365%
Anhui Huangshan Capsule Co., Ltd.	64.86 Million CNY	637.421%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	110.43 Million CNY	415.66%
Zhuhai Rundu Pharmaceutical Co., Ltd.	66.89 Million CNY	621.072%
Huaren Pharmaceutical Co., Ltd.	188.06 Million CNY	285.358%
Tianjin Ringpu Bio-Technology Co.,Ltd.	452.94 Million CNY	176.961%
Shanxi Zhendong Pharmaceutical Co.,Ltd	-43.98 Million CNY	-692.536%
Fuan Pharmaceutical (Group) Co., Ltd.	231.86 Million CNY	250.339%
Hybio Pharmaceutical Co., Ltd.	-513.87 Million CNY	32.165%
Baotou Dongbao Bio-Tech Co.,Ltd	119.88 Million CNY	390.769%
Hunan Er-Kang Pharmaceutical Co., Ltd	-195.32 Million CNY	-78.469%
Changjiang Pharmaceutical Group Co., Ltd.	-605.65 Million CNY	42.444%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	192.34 Million CNY	281.228%
Beijing Science Sun Pharmaceutical Co., Ltd.	102.91 Million CNY	438.707%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	64.35 Million CNY	641.655%
Hainan Poly Pharm. Co., Ltd	85.92 Million CNY	505.701%
Jiangxi Synergy Pharmaceutical Co., Ltd.	105.98 Million CNY	428.91%
Wuhan Hiteck Biological Pharma Co.,Ltd	-120.82 Million CNY	-188.513%
Shandong Xinhua Pharmaceutical Company Limited	496.51 Million CNY	170.208%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	27.35 Million CNY	1374.12%
PharmaBlock Sciences (Nanjing), Inc.	197.36 Million CNY	276.626%
Jinghua Pharmaceutical Group Co., Ltd.	247.69 Million CNY	240.732%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-420.05 Million CNY	17.013%
Betta Pharmaceuticals Co., Ltd.	348.03 Million CNY	200.16%
Tibet AIM Pharm. Inc.	15.38 Million CNY	2365.56%
Shenzhen Kangtai Biological Products Co., Ltd.	861.3 Million CNY	140.472%
Shandong Shanda Wit Science and Technology Co., Ltd.	585.26 Million CNY	159.561%
Pacific Shuanglin Bio-pharmacy Co., LTD	612.11 Million CNY	156.949%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	138.37 Million CNY	351.922%
Xiamen Kingdomway Group Company	276.71 Million CNY	225.976%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	25.19 Million CNY	1483.535%
Walvax Biotechnology Co., Ltd.	419.39 Million CNY	183.118%
Sunflower Pharmaceutical Group Co.,Ltd	1.11 Billion CNY	131.148%
Harbin Gloria Pharmaceuticals Co., Ltd	120.33 Million CNY	389.685%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	2.85 Billion CNY	112.219%
Hunan Hansen Pharmaceutical Co., Ltd.	205.01 Million CNY	270.031%
Changzhou Qianhong Biopharma CO.,LTD	181.86 Million CNY	291.68%
Shenzhen Weiguang Biological Products Co., Ltd.	218.65 Million CNY	259.427%
Honz Pharmaceutical Co., Ltd.	11.52 Million CNY	3123.365%
Northeast Pharmaceutical Group Co., Ltd.	358.45 Million CNY	197.247%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	43.93 Million CNY	893.445%
Guizhou Xinbang Pharmaceutical Co., Ltd.	287.23 Million CNY	221.361%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	361.82 Million CNY	196.341%
Zhejiang Yatai Pharmaceutical Co., Ltd.	-11.87 Million CNY	-2835.008%
Zhejiang NHU Company Ltd.	2.7 Billion CNY	112.89%
ApicHope Pharmaceutical Co., Ltd	184.61 Million CNY	288.822%
Shanghai Kaibao Pharmaceutical CO.,Ltd	327.87 Million CNY	206.319%
Beijing SL Pharmaceutical Co., Ltd.	416.69 Million CNY	183.656%
Yunnan Baiyao Group Co.,Ltd	4.09 Billion CNY	108.515%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	61.64 Million CNY	665.455%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	161.53 Million CNY	315.798%
Guangdong Lifestrong Pharmacy Co., Ltd.	33.5 Million CNY	1140.514%
Huadong Medicine Co., Ltd	2.83 Billion CNY	112.279%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.03 Billion CNY	133.618%
Harbin Medisan Pharmaceutical Co., Ltd.	73.66 Million CNY	573.222%
LanZhou Foci Pharmaceutical Co.,Ltd.	67.18 Million CNY	618.814%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	506.63 Million CNY	168.805%
Beijing Beilu Pharmaceutical Co., Ltd	-71.75 Million CNY	-385.791%
Nanjing Hicin Pharmaceutical Co., Ltd.	36.31 Million CNY	1059.891%
Renhe Pharmacy Co., Ltd.	567.25 Million CNY	161.452%
Chongqing Pharscin Pharmaceutical Co., Ltd.	32.69 Million CNY	1166.052%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	563.08 Million CNY	161.907%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-661.13 Million CNY	47.274%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-414.51 Million CNY	15.903%

Global Stocks Search

Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ)

Net Income Summary of Fujian Cosunter Pharmaceutical Co., Ltd.

Annual Net Income Chart of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Net Income Comparison of Fujian Cosunter Pharmaceutical Co., Ltd.